Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Clinical trial NCT03301350 · COMPLETED
Trial details
- NCT number
- NCT03301350
- Sponsor
- University of Wisconsin, Madison
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2020-03-23
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.